EUROPEAN NEUROPSYCHOPHARMACOLOGY

Scope & Guideline

Unraveling the Complexities of the Central Nervous System

Introduction

Welcome to your portal for understanding EUROPEAN NEUROPSYCHOPHARMACOLOGY, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0924-977x
PublisherELSEVIER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1990 to 2024
AbbreviationEUR NEUROPSYCHOPHARM / Eur. Neuropsychopharmacol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'European Neuropsychopharmacology' focuses on the intricate relationships between neuroscience, pharmacology, and psychiatric disorders, aiming to advance knowledge in the field through rigorous research and innovative methodologies.
  1. Neuropsychopharmacology:
    The core focus of the journal is on neuropsychopharmacology, examining how drugs affect the brain and behavior, and exploring new pharmacological treatments for various psychiatric disorders.
  2. Biomarkers and Diagnostics:
    Research related to biomarkers for psychiatric conditions is prevalent, aiming to identify biological indicators that can aid in the diagnosis and treatment of mental health disorders.
  3. Clinical Trials and Treatment Efficacy:
    The journal places significant emphasis on clinical trials assessing the efficacy and safety of psychiatric medications, including novel treatments and repurposed drugs.
  4. Genetics and Epigenetics:
    There is a consistent focus on the genetic and epigenetic factors influencing psychiatric disorders, including the use of polygenic risk scores and genome-wide association studies.
  5. Translational Research:
    The journal encourages translational research that bridges the gap between laboratory findings and clinical applications, aiming to improve treatment strategies for mental health disorders.
  6. Neuroimaging and Brain Function:
    Neuroimaging studies are a key component, investigating brain structure and function in relation to psychiatric symptoms and treatment outcomes.
  7. Psychiatric Comorbidities:
    The exploration of comorbidities among psychiatric disorders, particularly how they interact with physical health and treatment responses, is a notable area of interest.
The journal has seen a rise in interest in several emerging themes, reflecting the evolving landscape of psychiatric research and treatment methodologies.
  1. Psychedelic Research:
    There is a growing body of research focusing on the therapeutic potential of psychedelics for various psychiatric conditions, including depression and anxiety, indicating a shift towards exploring alternative treatment modalities.
  2. Digital Psychiatry and Telehealth:
    The COVID-19 pandemic has accelerated interest in digital psychiatry, including telehealth solutions and mobile health applications, to enhance patient care and monitoring.
  3. Integrative Approaches to Mental Health:
    Emerging themes include integrative approaches that combine pharmacotherapy with psychotherapy, lifestyle interventions, and digital tools to enhance treatment outcomes.
  4. Neuroinflammation and Immune Response:
    Research exploring the links between neuroinflammation, immune responses, and psychiatric disorders is gaining momentum, highlighting the biological underpinnings of mental health conditions.
  5. Precision Psychiatry:
    An increasing focus on precision psychiatry, utilizing genetic, epigenetic, and environmental factors to tailor treatments to individual patients, is becoming prominent in published studies.
  6. Machine Learning and AI in Psychiatry:
    The application of machine learning and artificial intelligence in predicting treatment responses and understanding psychiatric disorders is an emerging trend, showcasing the integration of technology in mental health research.
  7. Gut-Brain Axis Research:
    Research into the gut-brain axis and its implications for mental health is rapidly expanding, with studies examining how gut microbiota influence psychiatric symptoms and treatment outcomes.

Declining or Waning

While the journal has evolved over time, certain themes have shown a decline in prominence, reflecting shifts in research interests and funding priorities.
  1. Traditional Pharmacotherapy:
    There appears to be a waning interest in traditional pharmacotherapy approaches, as newer and more innovative treatments, including psychedelic therapies and neuromodulation techniques, gain traction.
  2. Single-Disease Focus:
    Research focusing exclusively on single disease models is declining, with more studies adopting transdiagnostic approaches that consider overlapping symptoms and shared biological mechanisms.
  3. Basic Science without Clinical Application:
    There is a noticeable decrease in studies that focus solely on basic science without clear clinical applications, as the journal increasingly prioritizes research with direct implications for patient care.
  4. Longitudinal Studies without Genetic Components:
    Longitudinal studies that do not incorporate genetic or epigenetic analyses are becoming less common, as the integration of these factors is essential for understanding complex psychiatric disorders.

Similar Journals

Brain Communications

Transforming Research into Understanding
Publisher: OXFORD UNIV PRESSISSN: Frequency: 1 issue/year

Brain Communications is an esteemed, open-access academic journal published by Oxford University Press since 2019, focusing on the dynamic field of neuroscience. With a dedicated ISSN and an E-ISSN of 2632-1297, this journal aims to address the intricate relationships between brain functions, psychiatric disorders, and neurobiological mechanisms. The journal stands out in the academic realm, holding a prestigious Q1 ranking across several categories, including Biological Psychiatry, Cellular and Molecular Neuroscience, Neurology, and Psychiatry and Mental Health for 2023. Notably, it has also secured impressive Scopus ranks in various neuroscience and psychiatry fields, evidencing its commitment to high-quality research. With an impact factor reflective of its growing influence, Brain Communications provides accessible research findings to professionals, researchers, and students alike, fostering a deeper understanding of complex neurological phenomena. This innovative journal is pivotal for anyone involved in advancing knowledge in neuroscience and mental health.

NeuroImage-Clinical

Advancing Clinical Neuroimaging for Tomorrow's Breakthroughs
Publisher: ELSEVIER SCI LTDISSN: 2213-1582Frequency:

NeuroImage-Clinical is a premier open access journal published by Elsevier Science Ltd, dedicated to advancing the field of clinical neuroimaging and its applications in a variety of neurological disorders. With an ISSN of 2213-1582, this journal has established itself as a leading source of innovative research since its inception in 2012, now continuing through 2024. Recognized for its high impact, it occupies the top quartile (Q1) in prestigious categories such as Cognitive Neuroscience, Neurology, and Radiology, affirming its relevance in clinical and research settings. Its Scopus rankings further exemplify its significant contribution to the disciplines of Radiology and Neurology, consistently placing it among the top tiers of journals in these fields. This journal not only provides critical insights for researchers and professionals but also serves as a valuable resource for students, fostering an understanding of the complexities in neuroimaging techniques and their implications for patient care. With open access options ensuring broad dissemination of knowledge, NeuroImage-Clinical plays a pivotal role in enhancing collaboration and innovation within the global neuroscience community.

MOLECULAR PSYCHIATRY

Advancing the Frontiers of Mental Health Research
Publisher: SPRINGERNATUREISSN: 1359-4184Frequency: 12 issues/year

MOLECULAR PSYCHIATRY, published by SpringerNature, is a premier peer-reviewed journal that has established itself as a leading platform for the dissemination of cutting-edge research in the fields of neuroscience, molecular biology, and psychiatry. With an impressive impact factor and a reputation for excellence, the journal is ranked Q1 in key categories, signifying its high academic quality and relevance. The journal’s scope spans groundbreaking studies and innovative therapeutic approaches that intersect at the molecular and cellular levels, providing invaluable insights into the biological underpinnings of psychiatric disorders. Since its inception in 1996, MOLECULAR PSYCHIATRY has evolved to support both established and emerging researchers, fostering a collaborative environment that enhances the understanding of mental health. It is committed to improving access to scientific knowledge, although it currently does not offer open access options. With its headquarters in London, the journal continues to play a pivotal role in enhancing the global dialogue on psychiatric and neurological advancements, making it an essential resource for academics and professionals dedicated to advancing mental health sciences.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Fostering Insights into Brain Function and Mental Health
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0278-5846Frequency: 8 issues/year

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, published by PERGAMON-ELSEVIER SCIENCE LTD, is a leading peer-reviewed journal that serves the interdisciplinary field of neuropsychopharmacology and biological psychiatry. With an impressive impact factor in the first quartile of both Biological Psychiatry and Pharmacology categories, this journal provides a critical platform for the dissemination of cutting-edge research and innovative therapeutic approaches. Covering a broad range of topics from the molecular mechanisms underlying psychiatric disorders to advanced pharmacological interventions, it aims to foster scientific dialogue among researchers, clinicians, and students alike. The journal has been at the forefront of scientific inquiry since its inception in 1982 and continues to evolve, adapting to the ever-changing landscape of neuroscience and mental health research. With its focus on high-quality articles and a commitment to advancing the understanding of neuropsychopharmacology, this journal is essential for anyone interested in the complexities of brain function and mental health.

Biological Psychiatry

Unraveling the complexities of psychiatric disorders through biology.
Publisher: ELSEVIER SCIENCE INCISSN: 0006-3223Frequency: 24 issues/year

Biological Psychiatry is a premier journal dedicated to advancing the understanding of the biological underpinnings of psychiatric disorders. Published by Elsevier Science Inc, this esteemed journal is recognized globally for its rigorous peer-reviewed research and contributes significantly to the field of biological psychiatry. With an impressive impact factor that places it in Q1 of its category and ranks 3rd out of 51 in Neuroscience Biological Psychiatry, it reflects the journal's strength in disseminating high-quality findings that push the boundaries of knowledge. Since its inception in 1969, the journal has undergone continuous evolution, aiming to integrate biological and clinical perspectives to optimize the understanding of mental health conditions. Although it does not offer open access, Biological Psychiatry serves as a critical resource for researchers, practitioners, and students, offering insights that influence both theoretical frameworks and practical applications in the realm of psychiatric science.

BEHAVIOURAL PHARMACOLOGY

Exploring the Nexus of Mind and Medicine
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0955-8810Frequency: 8 issues/year

Behavioural Pharmacology is a distinguished academic journal published by Lippincott Williams & Wilkins, focusing on the intricate relationship between pharmacology, psychiatry, and behavioral science. With an ISSN of 0955-8810 and an E-ISSN of 1473-5849, this journal serves as a vital platform for researchers and professionals dedicated to exploring the pharmacological mechanisms underlying behavior and mental health. Operating with a robust track record since its inception in 1992, it has established itself in the academic community, as reflected by its Q3 rankings in both the pharmacology and psychiatry categories for 2023. Additionally, the journal holds a credible position in Scopus rankings, with a percentile ranking indicative of significant contributions to the fields of pharmacology and psychiatry. Aimed at advancing knowledge and disseminating research in the behavioral pharmacology domain, this journal is an essential resource for students, researchers, and clinical professionals seeking to stay at the forefront of this rapidly evolving field. While it is not an open access journal, the rich content and research findings published here continue to foster collaboration and innovation within the community, making it a crucial reference point for current and future studies.

Neurosciences

Unveiling new perspectives in the study of the mind and brain.
Publisher: RIYADH ARMED FORCES HOSPITALISSN: 1319-6138Frequency: 4 issues/year

Neurosciences is a premier academic journal dedicated to the exploration of neurological and psychiatric disorders, fostering an innovative exchange of ideas and research findings in these critical fields. Published by the Riyadh Armed Forces Hospital in Saudi Arabia, this interdisciplinary journal has consistently contributed to the advancement of knowledge since its inception in 2002 and is set to continue through 2024. With an ISSN of 1319-6138 and E-ISSN of 1658-3183, it is recognized for its emphasis on clinically relevant research in neurology and psychiatry, boasting a 2023 classification in the Q3 tier of both categories. Neurosciences encourages submissions that offer novel insights into mental health and neurological conditions, positioning itself as a vital resource for researchers, healthcare professionals, and students alike. Despite being unlisted as an open-access journal, it remains a respected outlet for peer-reviewed content, with Scopus rankings that highlight its growing influence within the scientific community. This journal serves as an essential platform for disseminating significant research that addresses the intricacies of the human brain and behavior.

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging

Transforming Psychiatric Research with Innovative Techniques
Publisher: ELSEVIERISSN: 2451-9022Frequency: 12 issues/year

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging is a leading interdisciplinary journal published by Elsevier, focusing on the convergence of biological psychiatry, cognitive neuroscience, and advanced neuroimaging techniques. With its prestigious Q1 rankings across essential categories such as Biological Psychiatry, Cognitive Neuroscience, and Neurology (clinical), this journal is at the forefront of research that examines the complexities of mental health through innovative methodologies. Covering a broad spectrum of topics from neurobiological mechanisms to clinical applications, it aims to provide a platform for scholars and practitioners to exchange insights on mental disorders and their neurobiological underpinnings. The impact factor and Scopus rankings further underscore its importance, with rankings highlighting its position in the top percentiles of related disciplines. By fostering an open exchange of ideas and promoting cutting-edge research, this journal is an essential resource for researchers, professionals, and students dedicated to advancements in the understanding and treatment of psychiatric and neurological conditions.

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Empowering Psychiatry Through Research
Publisher: SAGE PUBLICATIONS INCISSN: 0706-7437Frequency: 12 issues/year

Canadian Journal of Psychiatry-Revue Canadienne de Psychiatrie, published by SAGE Publications Inc, has established itself as a leading voice in the field of psychiatry and mental health since its inception in 1979. With an impact factor that places it in the top quartile (Q1) of its category as of 2023, this journal ranks impressively at #112 out of 567 in the Scopus database, highlighting its significance and influence in the academic community. The journal provides a vital platform for disseminating cutting-edge research, innovative methodologies, and critical reviews, making it an essential resource for researchers, practitioners, and students alike. Although it currently does not offer open access, the journal's commitment to advancing the understanding of psychiatric disorders and mental health issues is unwavering. Situated in Canada, it serves both a national and international audience, fostering collaboration and knowledge sharing across disciplines. As the journal continues to evolve through 2024, it remains dedicated to enhancing the quality of mental health care and promoting the importance of psychiatric research.

Annals of General Psychiatry

Championing Impactful Research in Psychiatry
Publisher: BMCISSN: Frequency: 1 issue/year

Annals of General Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. Since its inception in 2005, the journal has provided a robust platform for researchers to disseminate peer-reviewed clinical and experimental studies, case reports, and reviews that address the broad spectrum of psychiatric disorders. With an impressive Q1 ranking in Psychiatry and Mental Health for 2023, and a notable Scopus rank of #128 out of 567 in its category, the journal plays a pivotal role in disseminating high-quality, impactful research within the global scientific community. The open access model guarantees wide visibility and accessibility of research findings, ensuring that professionals, students, and policymakers can utilize the latest advancements in the psychiatric field. The journal's presence from 2002 to 2024 further demonstrates its commitment to contributing valuable insights that are relevant to contemporary challenges in mental health.